• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期心衰治疗:规范缓和医疗的角色并描绘心脏移植辅助装置终末期心衰治疗之旅。

Destination Therapy: Standardizing the Role of Palliative Medicine and Delineating the DT-LVAD Journey.

机构信息

Mayo Clinic Arizona and Arizona State University, Phoenix, Arizona.

Department of Cardiothoracic Surgery, Mayo Clinic Arizona, Phoenix, Arizona.

出版信息

J Pain Symptom Manage. 2019 Feb;57(2):330-340.e4. doi: 10.1016/j.jpainsymman.2018.11.007. Epub 2018 Nov 15.

DOI:10.1016/j.jpainsymman.2018.11.007
PMID:30447385
Abstract

CONTEXT

Destination therapy (DT) patients face significant challenges as they transition from chronic left ventricular assist device (LVAD) support to comfort-oriented care. Integration of palliative medicine (PM) into the multidisciplinary team is important to facilitate advanced care planning (ACP) and improve quality of life (QoL).

OBJECTIVES

We evaluated the impact of a structured programmatic approach to the end-of-life (EOL) process in DT patients as measured by QoL surveys and the utilization of ACP.

METHODS

We instituted a four prong intervention approach: 1) delineated the path from implant to EOL by defining specific stages, including a transitional phase where care limits were agreed upon, 2) standardized the role of PM, 3) held transitional care meetings to support shared decision-making, and 4) held multidisciplinary team debriefings to facilitate communication. Preintervention and postintervention outcomes were measured for patients/caregivers by using the QUAL-E/QUAL-E (family) QoL instrument. Wilcoxon signed-ranks test compared nonparametric variables.

RESULTS

All patients (n = 41)/caregivers (n = 28) reported improved QoL measures (patient P = 0.035/caregiver P = 0.046). Preparedness plans increased from 52% to 73% after implementation and advance directives increased from 71% to 83%. Fifty-nine percent of the patients completed an outpatient PM clinic visit; 51% completed/scheduled a second visit. Clinician outcomes improved including satisfaction with multidisciplinary team communication/expectations, ACP processes, and EOL management.

CONCLUSION

A programmatic approach that standardizes the role of PM and delineates the patient's path from implant to EOL improved quality outcomes and increased implementation of ACP. A defined communication process allowed the multidisciplinary team to have a clear patient management approach.

摘要

背景

接受心脏移植手术的患者在从慢性左心室辅助装置(LVAD)支持过渡到舒适护理时面临重大挑战。姑息治疗(PM)融入多学科团队对于促进高级医疗计划(ACP)和提高生活质量(QoL)非常重要。

目的

我们通过 QoL 调查和 ACP 使用评估 DT 患者临终过程中结构化程序方法的影响。

方法

我们采用了四步干预方法:1)通过定义特定阶段(包括同意护理限制的过渡阶段)来划定从植入到临终的路径,2)规范 PM 的角色,3)召开过渡护理会议以支持共同决策,4)召开多学科团队汇报会以促进沟通。使用 QUAL-E/QUAL-E(家庭)QoL 仪器测量患者/照顾者的干预前后结果。采用 Wilcoxon 符号秩检验比较非参数变量。

结果

所有患者(n=41)/照顾者(n=28)报告 QoL 测量值均有改善(患者 P=0.035/照顾者 P=0.046)。实施后准备计划从 52%增加到 73%,预立医疗指示从 71%增加到 83%。59%的患者完成了门诊 PM 诊所就诊;51%的患者完成/安排了第二次就诊。临床医生的结果得到改善,包括对多学科团队沟通/期望、ACP 流程和临终管理的满意度。

结论

一种标准化 PM 角色并划定患者从植入到临终路径的程序方法改善了质量结果并增加了 ACP 的实施。明确的沟通流程使多学科团队能够有明确的患者管理方法。

相似文献

1
Destination Therapy: Standardizing the Role of Palliative Medicine and Delineating the DT-LVAD Journey.终末期心衰治疗:规范缓和医疗的角色并描绘心脏移植辅助装置终末期心衰治疗之旅。
J Pain Symptom Manage. 2019 Feb;57(2):330-340.e4. doi: 10.1016/j.jpainsymman.2018.11.007. Epub 2018 Nov 15.
2
Perceptions of Bereaved Caregivers and Clinicians About End-of-Life Care for Patients With Destination Therapy Left Ventricular Assist Devices.临终关怀患者及其临床医生对采用终末期心衰治疗的患者接受左心室辅助装置治疗的看法。
J Am Heart Assoc. 2021 Aug 3;10(15):e020949. doi: 10.1161/JAHA.121.020949. Epub 2021 Jul 26.
3
Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy-Challenges to Measuring Impact and Change in Institutional Culture.接受左心室辅助装置作为终末期治疗患者的姑息治疗与预案规划——衡量机构文化影响与变化的挑战
J Pain Symptom Manage. 2017 Aug;54(2):231-236. doi: 10.1016/j.jpainsymman.2016.10.372. Epub 2017 Jan 16.
4
Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy.接受左心室辅助装置作为终末期治疗的患者的姑息治疗咨询,以进行预备计划。
Mayo Clin Proc. 2011 Jun;86(6):493-500. doi: 10.4065/mcp.2010.0747.
5
Self-care and communication issues at the end of life of recipients of a left-ventricular assist device as destination therapy.左心室辅助装置作为终末期心力衰竭的靶心治疗受体的自我护理和沟通问题。
Curr Opin Support Palliat Care. 2013 Mar;7(1):29-35. doi: 10.1097/SPC.0b013e32835d2d50.
6
Ethical Challenges in Care of Patients on Mechanical Circulatory Support at End-of-Life.生命终末期机械循环支持患者治疗中的伦理挑战。
Curr Heart Fail Rep. 2020 Aug;17(4):153-160. doi: 10.1007/s11897-020-00460-4.
7
Advance care planning for patients with advanced neurology diseases.晚期神经疾病患者的预先护理计划。
Ann Palliat Med. 2018 Jul;7(3):349-354. doi: 10.21037/apm.2017.09.10. Epub 2017 Oct 13.
8
Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy.以左心室辅助装置作为终末期治疗的患者的姑息治疗和临终问题。
Curr Heart Fail Rep. 2011 Sep;8(3):212-8. doi: 10.1007/s11897-011-0060-x.
9
Improving Caregivers' Perceptions Regarding Patient Goals of Care/End-of-Life Issues for the Multidisciplinary Critical Care Team.改善多学科重症监护团队中护理人员对患者护理目标/临终问题的认知。
J Intensive Care Med. 2017 Jan;32(1):68-76. doi: 10.1177/0885066615606063. Epub 2015 Sep 28.
10
[Palliative care in patients with left ventricular assist devices: systematic review].[左心室辅助装置患者的姑息治疗:系统评价]
Anaesthesist. 2021 Dec;70(12):1044-1050. doi: 10.1007/s00101-021-00967-y. Epub 2021 Apr 30.

引用本文的文献

1
Feasibility of frailty screening among patients with advanced heart failure.衰弱筛查在晚期心力衰竭患者中的可行性。
BMJ Open Qual. 2023 Oct;12(4). doi: 10.1136/bmjoq-2023-002430.
2
Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care.晚期心力衰竭患者转诊至专科姑息治疗的标准。
J Am Coll Cardiol. 2022 Jul 26;80(4):332-344. doi: 10.1016/j.jacc.2022.04.057.
3
Inpatient Specialist Palliative Care in Patients With Left Ventricular Assist Devices (LVAD): A Retrospective Case Series.左心室辅助装置(LVAD)患者的住院专科姑息治疗:一项回顾性病例系列研究。
Front Cardiovasc Med. 2022 Jun 29;9:879378. doi: 10.3389/fcvm.2022.879378. eCollection 2022.
4
Existential Quality of Life and Associated Factors in Cancer Patients Receiving Palliative Care.癌症患者接受姑息治疗的存在质量及其相关因素。
J Pain Symptom Manage. 2022 Jan;63(1):61-70. doi: 10.1016/j.jpainsymman.2021.07.016. Epub 2021 Jul 29.
5
[Palliative care in patients with left ventricular assist devices: systematic review].[左心室辅助装置患者的姑息治疗:系统评价]
Anaesthesist. 2021 Dec;70(12):1044-1050. doi: 10.1007/s00101-021-00967-y. Epub 2021 Apr 30.
6
Referral Criteria to Palliative Care for Patients With Heart Failure: A Systematic Review.心力衰竭患者转诊至姑息治疗的标准:系统评价。
Circ Heart Fail. 2020 Sep;13(9):e006881. doi: 10.1161/CIRCHEARTFAILURE.120.006881. Epub 2020 Sep 9.